Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

CREDO THERAPIES LTD

Company number 14441022

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
06 May 2024 AA Total exemption full accounts made up to 31 December 2023
05 Apr 2024 AP01 Appointment of Joel Schoppig as a director on 27 March 2024
05 Apr 2024 TM01 Termination of appointment of Liliane Chamas as a director on 27 March 2024
21 Feb 2024 TM01 Termination of appointment of Cristian Oancea as a director on 14 February 2024
02 Feb 2024 AD01 Registered office address changed from 1 Vincent Square London SW1P 2PN England to 8 King Edward Street Oxford OX1 4HL on 2 February 2024
19 Jan 2024 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
21 Nov 2023 AP01 Appointment of Lingyun Shao as a director on 1 September 2023
06 Nov 2023 CS01 Confirmation statement made on 24 October 2023 with updates
13 Jun 2023 SH01 Statement of capital following an allotment of shares on 30 May 2023
  • GBP 208.224
12 Jun 2023 AA01 Current accounting period extended from 31 October 2023 to 31 December 2023
29 Dec 2022 MA Memorandum and Articles of Association
23 Dec 2022 AP01 Appointment of Dr Rebecca Anne Murphy as a director on 5 December 2022
22 Dec 2022 AP01 Appointment of Ms Liliane Chamas as a director on 5 December 2022
16 Dec 2022 PSC02 Notification of Oxford Science Enterprises Plc as a person with significant control on 5 December 2022
16 Dec 2022 PSC07 Cessation of Cristian Oancea as a person with significant control on 1 December 2022
16 Dec 2022 PSC07 Cessation of David James Bateman as a person with significant control on 1 December 2022
16 Dec 2022 AP01 Appointment of Mr David James Bateman as a director on 5 December 2022
16 Dec 2022 SH01 Statement of capital following an allotment of shares on 5 December 2022
  • GBP 165.82
16 Dec 2022 SH01 Statement of capital following an allotment of shares on 1 December 2022
  • GBP 116.47
25 Oct 2022 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2022-10-25
  • GBP 6.25